The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Cryptogenic fibrosing alveolitis: clinical features and their influence on survival
Open accessAbstract
A retrospective analysis of 220 cases fulfilling criteria for cryptogenic fibrosing alveolitis (CFA) attending the Brompton Hospital between 1955 and 1973 has been carried out and patients have been followed for between four and 21 years. The frequency of various clinical features confirms previous reports. The 2: 1 male preponderance was similar in all age groups. The mean age at presentation was 54 years ± 12 SD; 202 (92%) of the patients presented with dyspnoea, the severity of which was related to the reduction in vital capacity (p<0·003) and to the radiographic profusion score (p<0·01) but not to its duration. Twenty-one per cent of the 220 had joint symptoms, 10% having clinical rheumatoid arthritis. Eleven per cent had other types of connective tissue disorder. In all, 30% had polyarthritis or other immunological disorders and 70% lone CFA. Apart from an increase in rheumatoid factor in those with polyarthritis, there were no other clinical or survival differences between those with and without associated immunological disease. Forty-five per cent of 205 subjects had antinuclear antibody, and this occurred equally in those with and without associated connective tissue disorders. One hundred and forty-seven initial radiographs were available for reclassification using the ILO/UC system and only three were normal. Small rounded opacities were seen in 16% and small irregular opacities in 84%. Pleural changes were uncommon. Histological confirmation had been obtained in 118 patients and material was still available for review using a semiquantitative analysis in 68 (biopsy 42 and necropsy 26). Of the biopsies one could be classified as desquamative interstitial pneumonia (DIP) and 17 as endstage fibrosis; the other 24 showed a mixed cellular and fibrotic pattern. The necropsy material showed much greater fibrosis and less acute inflammatory cellularity in spite of an interval between onset of symptoms and death of less than four years in 21 of 26 patients. One hundred and fifty-six patients have died (mean survival 3·2 years). Eleven (5%) are believed to be alive but have been lost to follow-up. Fifty-five per cent of deaths were attributable directly or indirectly to CFA. There was also an excess of deaths from cardiovascular disease and lung cancer. Using a life-table analysis and a log rank test, longer survival was seen in younger patients (p<0·001) and women (p<0·01). After correction for age and sex, lesser grades of dyspnoea (p<0·03) and lesser radiographic abnormality (p<0·001), absence of right axis deviation (p<0·001), and a higher Pao2 (p<0·01) also related to longer survival. Subjects with more cellular histology also survived longer (p<0·02). Factors having no influence on survival included duration of dyspnoea before presentation, degree of reduction of FEV1, FVC, and TLC, the presence of “connective tissue” disorders, autoantibodies, smoking history, cough, sputum, crackles, clubbing, ESR, or immunoglobulins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Natural History and Treated Course of Usual and Desquamative Interstitial Pneumonia
Carrington, C. B., Gaensler, E. A., Coutu, R. E., FitzGerald, M. X., & Gupta, R. G. (1978) · New England Journal of Medicine · doi:10.1056/nejm197804132981501 · Cited by 791
CRYSTAL, R. G., FULMER, J. D., ROBERTS, W. C., MOSS, M. L., LINE, B. R., & REYNOLDS, H. Y. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-6-769 · Cited by 685
Cryptogenic fibrosing alveolitis and lung cancer.
Turner-Warwick, M., Lebowitz, M., Burrows, B., & Johnson, A. (1980) · Thorax · doi:10.1136/thx.35.7.496 · Cited by 349
Self-citationCirculating Immune Complexes in the Idiopathic Interstitial Pneumonias
Dreisin, R. B., Schwarz, M. I., Theofilopoulos, A. N., & Stanford, R. E. (1978) · New England Journal of Medicine · doi:10.1056/nejm197802162980701 · Cited by 278
Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival
Turner-Warwick, M., Burrows, B., & Johnson, A. (1980) · Thorax · doi:10.1136/thx.35.8.593 · Cited by 244
Self-citationThe prognosis of cryptogenic fibrosing alveolitis
Stack, B. H. R., Choo-Kang, Y. F. J., & Heard, B. E. (1972) · Thorax · doi:10.1136/thx.27.5.535 · Cited by 240
Antibodies in some chronic fibrosing lung diseases
Warwick, M. T., & HASLAM, P. L. (1971) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1971.tb02450.x · Cited by 80
Cited by
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Selman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,786
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z., & Oster, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-163oc · Cited by 1,310
Idiopathic Pulmonary Fibrosis: Clinical Relevance of Pathologic Classification
KATZENSTEIN, A.-L. A., & MYERS, J. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707039 · Cited by 1,261
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
BJORAKER, J. A., RYU, J. H., EDWIN, M. K., MYERS, J. L., TAZELAAR, H. D., SCHROEDER, D. R., & OFFORD, K. P. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9704130 · Cited by 1,039
Gross, T. J., & Hunninghake, G. W. (2001) · New England Journal of Medicine · doi:10.1056/nejmra003200 · Cited by 962
The epidemiology of interstitial lung diseases.
Coultas, D. B., Zumwalt, R. E., Black, W. C., & Sobonya, R. E. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.4.7921471 · Cited by 946
Interstitial lung disease guideline
Wells, A. U., Hirani, N., & on behalf of the BTS Interstitial Lung Disease Guideline Group, A. S. O. T. B. T. S. S. O. C. C. (2008) · Thorax · doi:10.1136/thx.2008.101691 · Cited by 866
Predicting Survival in Idiopathic Pulmonary Fibrosis
KING, T. E., TOOZE, J. A., SCHWARZ, M. I., BROWN, K. R., & CHERNIACK, R. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2003140 · Cited by 853
Crystal, R. G., Bitterman, P. B., Rennard, S. I., Hance, A. J., & Keogh, B. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198401193100304 · Cited by 690
Prevalence, pathogenesis, and causes of chronic cough
Chung, K. F., & Pavord, I. D. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60595-4 · Cited by 665
Idiopathic Pulmonary Fibrosis: Relationship between Histopathologic Features and Mortality
KING, T. E., SCHWARZ, M. I., BROWN, K., TOOZE, J. A., COLBY, T. V., WALDRON, J. A., FLINT, A., THURLBECK, W., & CHERNIACK, R. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.6.2001056 · Cited by 628
Park, J. H., Kim, D. S., Park, I.-N., Jang, S. J., Kitaichi, M., Nicholson, A. G., & Colby, T. V. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-912oc · Cited by 597
Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature
Nalysnyk, L., Cid-Ruzafa, J., Rotella, P., & Esser, D. (2012) · European Respiratory Review · doi:10.1183/09059180.00002512 · Cited by 552
Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease.
Bernstein, R. M., Morgan, S. H., Chapman, J., Bunn, C. C., Mathews, M. B., Turner-Warwick, M., & Hughes, G. R. (1984) · BMJ · doi:10.1136/bmj.289.6438.151 · Cited by 548
Self-citationAcute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features
Kim, D. S., Park, J. H., Park, B. K., Lee, J. S., Nicholson, A. G., & Colby, T. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00114004 · Cited by 497
NICHOLSON, A. G., COLBY, T. V., DUBOIS, R. M., HANSELL, D. M., & WELLS, A. U. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.6.2003049 · Cited by 489
New Serum Indicator of Interstitial Pneumonitis Activity
Nobuoki, K., Seishi, K., Yukikazu, A., Hirofumi, F., Michio, Y., & Mitoshi, A. (1989) · Chest · doi:10.1378/chest.96.1.68 · Cited by 486
RAGHU, G., CRAIG JOHNSON, W., LOCKHART, D., & MAGETO, Y. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.4.9805017 · Cited by 468
Acute Exacerbation in Idiopathic Pulmonary Fibrosis
Kondoh, Y., Taniguchi, H., Kawabata, Y., Yokoi, T., Suzuki, K., & Takagi, K. (1993) · Chest · doi:10.1378/chest.103.6.1808 · Cited by 457
Raghu, G., Depaso, W. J., Cain, K., Hammar, S. P., Wetzel, C. E., Dreis, D. F., Hutchinson, J., Pardee, N. E., & Winterbauer, R. H. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.2.291 · Cited by 414
Meltzer, E. B., & Noble, P. W. (2008) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-3-8 · Cited by 407
Desai, S. R., Veeraraghavan, S., Hansell, D. M., Nikolakopolou, A., Goh, N. S. L., Nicholson, A. G., Colby, T. V., Denton, C. P., Black, C. M., du Bois, R. M., et al. (2004) · Radiology · doi:10.1148/radiol.2322031223 · Cited by 394
Is Idiopathic Pulmonary Fibrosis an Environmental Disease?
Taskar, V. S., & Coultas, D. B. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200512-131tk · Cited by 383
DANIIL, Z. D., GILCHRIST, F. C., NICHOLSON, A. G., HANSELL, D. M., HARRIS, J., COLBY, T. V., & du BOIS, R. M. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9903021 · Cited by 381
Baumgartner, K. B., Samet, J. M., Coultas, D. B., Stidley, C. A., Hunt, W. C., Colby, T. V., Waldron, J. A., & Centers, C. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.4.307 · Cited by 374
Long-term Course and Prognosis of Idiopathic Pulmonary Fibrosis in the New Millennium
Nathan, S. D., Shlobin, O. A., Weir, N., Ahmad, S., Kaldjob, J. M., Battle, E., Sheridan, M. J., & du Bois, R. M. (2011) · Chest · doi:10.1378/chest.10-2572 · Cited by 369
Koduri, G., Norton, S., Young, A., Cox, N., Davies, P., Devlin, J., Dixey, J., Gough, A., Prouse, P., Winfield, J., et al. (2010) · Rheumatology · doi:10.1093/rheumatology/keq035 · Cited by 369
Clinical deterioration in patients with idiopathic pulmonary fibrosis: Causes and assessment
Panos, R. J., Mortenson, R. L., Niccoli, S. A., & King, T. E. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90495-y · Cited by 367
Age and sex associations of 40 autoimmune diseases
Beeson, P. B. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90173-2 · Cited by 352
Determinants of survival in idiopathic pulmonary fibrosis.
Schwartz, D. A., Helmers, R. A., Galvin, J. R., Van Fossen, D. S., Frees, K. L., Dayton, C. S., Burmeister, L. F., & Hunninghake, G. W. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.2.8306044 · Cited by 340
Nagai, S., Kitaichi, M., Itoh, H., Nishimura, K., Izumi, T., & Colby, T. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12051010 · Cited by 339
Combined Pulmonary Fibrosis and Emphysema Syndrome
Jankowich, M. D., & Rounds, S. I. S. (2012) · Chest · doi:10.1378/chest.11-1062 · Cited by 333
Clinical Advances in the Diagnosis and Therapy of the Interstitial Lung Diseases
King, T. E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200503-483oe · Cited by 330
Smoking-related interstitial lung diseases: a concise review
Ryu, J. H., Colby, T. V., Hartman, T. E., & Vassallo, R. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.17101220 · Cited by 318
Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis
Hubbard, R., Lewis, S., Richards, K., Johnston, I., & Britton, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90465-1 · Cited by 318
Hunninghake, G. W., Lynch, D. A., Galvin, J. R., Gross, B. H., Mu¨ller, N., Schwartz, D. A., King, T. E., Lynch, J. P., Hegele, R., Waldron, J., et al. (2003) · Chest · doi:10.1378/chest.124.4.1215 · Cited by 317
MacDonald, S. L. S., Rubens, M. B., Hansell, D. M., Copley, S. J., Desai, S. R., du Bois, R. M., Nicholson, A. G., Colby, T. V., & Wells, A. U. (2001) · Radiology · doi:10.1148/radiol.2213010158 · Cited by 310
Nicholson, A. G., Fulford, L. G., Colby, T. V., du Bois, R. M., Hansell, D. M., & Wells, A. U. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2109039 · Cited by 299
TAKAHASHI, H., FUJISHIMA, T., KOBA, H., MURAKAMI, S., KUROKAWA, K., SHIBUYA, Y., SHIRATORI, M., KUROKI, Y., & ABE, S. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.3.9910080 · Cited by 291
(1990) · European Respiratory Journal · doi:10.1183/09031936.93.03080937 · Cited by 290
Johnson, M. A., Kwan, S., Snell, N. J., Nunn, A. J., Darbyshire, J. H., & Turner-Warwick, M. (1989) · Thorax · doi:10.1136/thx.44.4.280 · Cited by 289
Self-citationIdiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure.
Iwai, K., Mori, T., Yamada, N., Yamaguchi, M., & Hosoda, Y. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.3.8087336 · Cited by 268
Pulmonary fibrosis: cytokines in the balance
Coker, R., & Laurent, G. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.11061218 · Cited by 267
Wells, A. U., Cullinan, P., Hansell, D. M., Rubens, M. B., Black, C. M., Newman-Taylor, A. J., & Du Bois, R. M. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.6.8004317 · Cited by 265
DOUGLAS, W. W., RYU, J. H., & SCHROEDER, D. R. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.9907002 · Cited by 259
Haslam, P. L., Turton, C. W. G., Heard, B., Lukoszek, A., Collins, J. V., Salsbury, A. J., & Turner-Warwick, M. (1980) · Thorax · doi:10.1136/thx.35.1.9 · Cited by 252
Self-citationBehr, J., Kreuter, M., Hoeper, M. M., Wirtz, H., Klotsche, J., Koschel, D., Andreas, S., Claussen, M., Grohé, C., Wilkens, H., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00217614 · Cited by 247
DOUGLAS, W. W., RYU, J. H., SWENSEN, S. J., OFFORD, K. P., SCHROEDER, D. R., CARON, G. M., & DeREMEE, R. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.1.9709089 · Cited by 182
Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts
Mapel, D. W., Hunt, W. C., Utton, R., Baumgartner, K. B., Samet, J. M., & Coultas, D. B. (1998) · Thorax · doi:10.1136/thx.53.6.469 · Cited by 120
In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases
PRIOR, C., & HASLAM, P. L. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb03074.x · Cited by 118
Rudd, R. M., Prescott, R. J., Chalmers, J. C., Johnston, I. D. A., & for the Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society (2007) · Thorax · doi:10.1136/thx.2005.045591 · Cited by 113
Metadata
- Authors
- Turner-Warwick, M., Burrows, B., & Johnson, A.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 1980-03-01
- Volume
- 35
- Issue
- 3
- Pages
- 171-180
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2096358180
- Cited by
- 508
- References
- 8
- FWCI
- 10.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.